alendronate has been researched along with Muscular Dystrophies in 1 studies
alendronic acid : A 1,1-bis(phosphonic acid) that is methanebis(phosphonic acid) in which the two methylene hydrogens are replaced by hydroxy and 3-aminopropyl groups.
Muscular Dystrophies: A heterogeneous group of inherited MYOPATHIES, characterized by wasting and weakness of the SKELETAL MUSCLE. They are categorized by the sites of MUSCLE WEAKNESS; AGE OF ONSET; and INHERITANCE PATTERNS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Three boys with muscular dystrophy with known osteoporosis were each treated for 1 yr with weekly alendronate and daily calcium and vitamin D." | 7.74 | Use of weekly alendronate to treat osteoporosis in boys with muscular dystrophy. ( Apkon, S; Coll, J, 2008) |
| "Three boys with muscular dystrophy with known osteoporosis were each treated for 1 yr with weekly alendronate and daily calcium and vitamin D." | 3.74 | Use of weekly alendronate to treat osteoporosis in boys with muscular dystrophy. ( Apkon, S; Coll, J, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Apkon, S | 1 |
| Coll, J | 1 |
1 other study available for alendronate and Muscular Dystrophies
| Article | Year |
|---|---|
Use of weekly alendronate to treat osteoporosis in boys with muscular dystrophy.
Topics: Alendronate; Bone Density; Bone Density Conservation Agents; Calcium; Child; Diphosphonates; Humans; | 2008 |